A股異動 | 藍海華騰(300484.SZ)直線拉昇漲超7% 與比亞迪電池簽署戰略合作框架協議
格隆匯7月10日丨藍海華騰(300484.SZ)午後直線拉昇,現報14.7元,漲7.3%,暫成交2.3億元,最新總市值30.6億元。藍海華騰午間宣佈,公司與比亞迪電池於2020年7月9日簽署《戰略合作框架協議》。雙方就電機控制器單元、集成式電控、動力電池、高壓直流繼電器、金屬化薄膜電容器、高壓直流熔斷器等產品的應用與推廣達成合作共識。公告稱,雙方合作有利於公司在電動汽車電機控制器及相關產品的技術推動和產業佈局。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.